Why the study?
The study evaluated pulse wave velocity as a vascular biomarker to predict and prevent early vascular aging during spaceflight.
Does a 6-month space flight increase pulse wave velocity and vascular risk in Russian cosmonauts?
Does a 6-month space flight increase pulse wave velocity and vascular risk in Russian cosmonauts?
A 6-month space flight in low-Earth orbit does not appear to increase pulse wave velocity or early vascular aging in cosmonauts.
May inform vascular monitoring in astronauts; leaves open translation to terrestrial risk assessment.
The article is devoted to the study of the state of the vascular wall based on the data on pulse wave velocity used as a vascular biomarker to predict and prevent early vascular aging. The studies were carried out on Russian cosmonauts who performed 6-month space flights using a Mobilograph device, which passed all the necessary tests, was certified for operation on board the International Space Station and allows evaluating the parameters of central hemodynamics. The experiment was carried out twice before the flight, every month during the flight, and also on days +4 and +8 after landing. Pulse wave velocity in all measurements was not shown to exceed the threshold values, thus suggesting the absence of vascular risk and the risk of cardiovascular pathologies in astronauts working in low-Earth orbit. However, this conclusion may be limited by the features of the method and the device used.
No takes yet. Share an insight, caveat, or question.
Luchitskaya et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: